[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:neuroendocrine-carcinoma:mki67-gene":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Neuroendocrine Carcinoma","MKI67 Gene",4,[8,16,23,30],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07544654","A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy",[12],"Phase 3","RECRUITING","2026-08-26T02:16:16.169331Z","2026-05-05T02:43:26.717266Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06202066","Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas",[20],"Phase 2","2026-08-03T02:57:18.103669Z","2026-05-05T02:43:29.222571Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT05652686","A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)",[27],"Phase 1\u002FPhase 2","2026-08-26T02:16:14.341106Z","2026-07-19T19:36:05.121911Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":35,"content_modified":36},"NCT05841563","Clinical Trial of PM54 in Advanced Solid Tumors Patients.",[34],"Phase 1","2026-08-26T02:15:18.897219Z","2026-05-05T02:43:26.706220Z"]